Literature DB >> 2386115

Usefulness of semiquantitative analysis of dipyridamole-thallium-201 redistribution for improving risk stratification before vascular surgery.

J R Levinson1, C A Boucher, C M Coley, T E Guiney, H W Strauss, K A Eagle.   

Abstract

Preoperative dipyridamole-thallium-201 scanning is sensitive in identifying patients prone to ischemic cardiac complications after vascular surgery, but most patients with redistribution do not have an event after surgery. Therefore, its positive predictive value is limited. To determine which patients with thallium redistribution are at highest risk, dipyridamole-thallium-201 images were interpreted semiquantitatively. Sixty-two consecutive patients with redistribution on preoperative dipyridamole-thallium-201 planar imaging studies were identified. Each thallium scan was then analyzed independently by 2 observers for the number of myocardial segments out of 15, the number of thallium views out of 3 and the number of coronary artery territories with redistribution. Seventeen patients (27%) had postoperative ischemic events, including unstable angina pectoris, ischemic pulmonary edema, myocardial infarction and cardiac death. Thallium predictors of ischemic operative complications included thallium redistribution greater than or equal to 4 myocardial segments (p = 0.03), greater than or equal to 2 of the 3 planar views (p = 0.005) and greater than or equal to 2 coronary territories (p = 0.007). No patient with redistribution in only 1 view had an ischemic event (0 of 15). Thus, determining the extent of redistribution by dipyridamole-thallium-201 scanning improves risk stratification before vascular surgery. Patients with greater numbers of myocardial segments and greater numbers of coronary territories showing thallium-201 redistribution are at higher risk for ischemic cardiac complications. In contrast, when the extent of thallium redistribution is limited, there is a lower risk despite the presence of redistribution.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2386115     DOI: 10.1016/0002-9149(90)90694-v

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

Review 1.  Perioperative care of the vascular surgery patient: the perspective of the internist.

Authors:  R Granieri; D S Macpherson
Journal:  J Gen Intern Med       Date:  1992 Jan-Feb       Impact factor: 5.128

Review 2.  Preoperative evaluation of the cardiac patient for noncardiac surgery.

Authors:  P G Barash
Journal:  Can J Anaesth       Date:  1991-05       Impact factor: 5.063

3.  The value of perioperative clinical indexes and dipyridamole thallium scintigraphy for the prediction of myocardial infarction and cardiac death in patients undergoing vascular surgery.

Authors:  R C Hendel; J A Leppo
Journal:  J Nucl Cardiol       Date:  1995 Jan-Feb       Impact factor: 5.952

4.  Preoperative risk stratification by adenosine thallium 201 single-photon emission computed tomography in patients undergoing vascular surgery.

Authors:  M G Koutelou; P J Asimacopoulos; J J Mahmarian; K T Kimball; M S Verani
Journal:  J Nucl Cardiol       Date:  1995 Sep-Oct       Impact factor: 5.952

5.  Dipyridamole technetium 99m sestamibi myocardial tomography as an independent predictor of cardiac event-free survival after acute ischemic events.

Authors:  D D Miller; H G Stratmann; L Shaw; B R Tamesis; M D Wittry; L T Younis; B R Chaitman
Journal:  J Nucl Cardiol       Date:  1994 Jan-Feb       Impact factor: 5.952

Review 6.  Preoperative cardiac risk assessment for noncardiac surgery.

Authors:  S A Abraham; K A Eagle
Journal:  J Nucl Cardiol       Date:  1994 Jul-Aug       Impact factor: 5.952

Review 7.  Cardiac evaluation and risk reduction in patients undergoing major vascular operations.

Authors:  D K Potyk
Journal:  West J Med       Date:  1994-07

8.  Prevalence and predictors of myocardial ischemia by preoperative myocardial perfusion single photon emission computed tomography in patients undergoing noncardiac surgery.

Authors:  Abdelkareem Saleh Al-Oweidi; Hesham Albabtain; Suleiman M Kharabsheh; Peter Kimme; Mahmoud Almustafa; Samer Seder; Mohamed Shoukri; Ahmed L Fathala
Journal:  Ann Saudi Med       Date:  2017 Nov-Dec       Impact factor: 1.526

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.